M&T BANK CORP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 165 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$230,000
-7.6%
6,788
-0.0%
0.00%0.0%
Q2 2021$249,000
-18.4%
6,7900.0%0.00%0.0%
Q1 2021$305,000
-13.4%
6,790
+10.0%
0.00%
-50.0%
Q4 2020$352,000
+12.8%
6,173
+1.4%
0.00%0.0%
Q3 2020$312,000
+7.2%
6,085
+24.9%
0.00%0.0%
Q2 2020$291,000
+5.4%
4,871
+10.0%
0.00%
+100.0%
Q4 2019$276,0004,4290.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders